2028 年亚太地区生物製程技术市场预测 - 按类型、模式和最终用户进行的区域分析
市场调查报告书
商品编码
1375195

2028 年亚太地区生物製程技术市场预测 - 按类型、模式和最终用户进行的区域分析

Asia Pacific Bioprocess Technology Market Forecast to 2028 - Regional Analysis By Type, Modality, and End User

出版日期: | 出版商: The Insight Partners | 英文 141 Pages | 订单完成后即时交付

价格

亚太生物製程技术市场预计将从2023年的46.0864亿美元成长到2028年的110.075亿美元。预计2023年至2028年复合年增长率为19.0%。

自动即时流式细胞仪 (ART-FCM) 的出现推动亚太生物製程技术市场

流式细胞仪 (FCM) 及其技术可能性在过去十年中取得了巨大进步,作为生物反应器中单细胞特性和不同细胞类型群体分布的分析工具。在此过程中,开发了一些自动化即时流式细胞仪 (ART-FCM) 解决方案,用于监测生物反应器过程,而无需操作员长时间干扰,且采样频率可变。 ART-FCM 能够实现长期测量,不会错过生物过程中的任何重要事件,并揭示可能未知且应进行更详细研究的时间现象。此外,可以按照使用者定义的频率执行更频繁的测量,而与人员的可用性无关。与仅在单细胞层级上部分可用的组学等方法相比,透过 ART-FCM 可以轻鬆建立多参数测量,而无需花费大量的人力和时间。与传统的FCM研究相比,微流控元件作为晶片上的ART-FCM具有巨大的未来潜力。在这种情况下,并行化可能变得更加相关,因为可以同时分析来自不同生物反应器或生物反应器设定内不同位置的样本。许多方面也可能适用于其他实验设置,其中萤光过程参数的快速且可重复的即时监测也令人感兴趣。总之,ART-FCM 很可能在未来几年呈指数级发展。

亚太地区生物製程技术市场概况

根据 BioPlan Associates 1000 强生物设施指数和生物製造商资料库报告,自过去十年以来,全球生物加工能力平均增加了 12%。中国作为小分子药物和大分子药物市场的全球参与者处于有利地位,分别占据全球第二和第三位。此外,由于中国拥有合约开发和製造组织 (CDMO) 基地,约占该国生物产能的 25%,中国也是多家细胞和基因治疗开发商的所在地。因此,中国拥有相当大的生物製造能力,但严格遵守全球GMP标准,这对生物製剂的安全性和有效性建立了信心。

亚太地区生物製程技术市场收入及 2028 年预测(百万美元)

亚太地区生物製程技术市场细分

亚太生物製程技术市场按类型、模式、最终用户和国家进行细分。

根据类型,亚太生物製程技术市场分为细胞培养基生物製程、色谱生物製程、消耗品和配件等。 2023年,耗材及配件领域在亚太生物製程技术市场中占据最大份额。

根据模式,亚太生物製程技术市场分为一次性和多次使用。 2023年,一次性细分市场在亚太生物製程技术市场中占据更大份额。

根据最终用途,亚太生物製程技术市场分为学术和医疗机构、生物製药公司、研究实验室等。 2023年,生物製药公司细分市场在亚太生物製程技术市场中占据最大份额。

依国家/地区划分,亚太地区生物製程技术市场分为中国、日本、印度、澳洲、韩国和亚太地区其他地区。 2023年,中国市场在亚太生物製程技术市场中占据最大份额。

康宁公司;丹纳赫公司;艾本德公司;龙沙集团股份公司;默克公司;雷普利根公司;赛多利斯公司;和 Thermo Fisher Scientific Inc 是亚太地区生物製程技术市场上的一些领先公司。

目录

第 1 章:简介

  • 研究范围
  • Insight Partners 研究报告指南
  • 市场区隔
    • 亚太地区生物製程技术市场 - 按类型
    • 亚太生物製程技术市场 - 按模式
    • 亚太生物製程技术市场 - 按最终用户划分
    • 亚太生物製程技术市场 - 按国家/地区

第 2 章:亚太地区生物製程技术市场 - 要点

第 3 章:研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章:亚太地区生物製程技术市场 - 市场格局

  • 概述
  • 亚太地区 PEST 分析
  • 专家意见

第 5 章:亚太地区生物製程技术市场 - 主要市场动态

  • 市场驱动因素
    • 不断增加研发支出以推出新药物化合物
    • 慢性病盛行率增加
  • 市场限制
    • 严格的监理政策
  • 市场机会
    • 引进先进的生物製程技术
  • 未来的趋势
    • 自动即时流式细胞仪 (ART-FCM) 的出现
  • 影响分析

第 6 章:生物製程技术市场 - 亚太地区分析

  • 亚太地区生物製程技术市场收入预测与分析

第 7 章:亚太地区生物製程技术市场 - 收入和 2028 年预测 - 按类型

  • 概述
  • 2022 年及 2028 年生物製程技术市场收入份额,按类型划分 (%)
  • 细胞培养基生物过程
  • 色谱生物过程
  • 耗材及配件
  • 其他的

第 8 章:2028 年亚太地区生物製程技术市场分析与预测 - 按模式

  • 概述
  • 亚太地区生物製程技术市场,按模式 2022 年和 2028 年 (%)
  • 单人使用
  • 多次使用

第 9 章:亚太地区生物製程技术市场 - 收入和 2028 年预测 - 按最终用户

  • 概述
  • 2022 年及 2028 年亚太地区生物製程技术市场收入份额(按最终用户划分)(%)
  • 学术及医疗机构
  • 生物製药公司
  • 研究实验室
  • 其他的

第 10 章:亚太地区生物製程技术市场 - 2028 年收入与预测 - 国家分析

    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 韩国
      • 澳洲
      • 亚太地区其他地区

第 11 章:亚太地区生物製程技术市场 - 产业格局

  • 概述
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第 12 章:公司简介

  • Merck KGaA
  • Sartorius AG
  • Thermo Fisher Scientific Inc
  • Corning Inc
  • Lonza Group AG
  • Eppendorf SE
  • Repligen Corp
  • Danaher Corp

第 13 章:附录

  • 关于 Insight Partners
  • 专业术语
Product Code: BMIRE00028868

The Asia Pacific bioprocess technology market is expected to grow from US$ 4,608.64 million in 2023 to US$ 11,000.75 million by 2028. It is estimated to grow at a CAGR of 19.0% from 2023 to 2028.

Emergence of Automated Real-Time Flow Cytometry (ART-FCM) Drive Asia Pacific Bioprocess Technology Market

Flow cytometry (FCM) and its technological possibilities have greatly advanced in the past decade as an analysis tool for single-cell properties and population distributions of different cell types in bioreactors. Along the way, a few automated Real-Time Flow Cytometry (ART-FCM) solutions were developed for monitoring bioreactor processes without operator interference over extended periods with a variable sampling frequency. ART-FCM enables s long-term measurements without missing any important events in bioprocesses and uncovers temporal phenomena that are likely unknown and should be investigated in greater detail. Also, more frequent measurements can be performed at a user-defined frequency, independent of the availability of personnel. When compared with methods such as omics that are only partially available on a single-cell level, multi-parameter measurements can be easily established without the extended effort of labor and time via ART-FCM. Compared with conventional FCM studies, microfluidic devices great future potential as ART-FCM on a chip. In this context, parallelization might become more relevant, as samples from different bioreactors or different locations inside a bioreactor setup could be analyzed simultaneously. Many aspects might also be adapted to other experimental setups where fast and reproducible real-time monitoring of fluorescent process parameters is also of interest. In conclusion, ART-FCM will most probably advance exponentially in the upcoming years.

Asia Pacific Bioprocess Technology Market Overview

The bioprocessing capacity globally has increased at an average of 12% since the past decade, as per the BioPlan Associates Top 1000 Biofacility Index and Biomanufacturers Database report. China is well positioned as a global participant in markets with both small and large-molecule drugs, accounting for second and third position, respectively, worldwide. Also, China is home to several developers of cell and gene therapy due to China's base for contract development and manufacturing organizations (CDMOs), accounting for ~25% of the country's bioproduction capacity. Therefore, China has considerable biomanufacturing capabilities but strict adherence to the global GMP standards that build confidence in the biologics' safety and effectiveness.

Asia Pacific Bioprocess Technology Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Bioprocess Technology Market Segmentation

The Asia Pacific bioprocess technology market is segmented into type, modality, end user, and country.

Based on type, the Asia Pacific bioprocess technology market is segmented into cell culture media bioprocess, chromatography bioprocess, consumables & accessories, and others. In 2023, the consumables & accessories segment registered the largest share in the Asia Pacific bioprocess technology market.

Based on modality, the Asia Pacific Bioprocess technology market is bifurcated into single use and multiple use. In 2023, the single use segment registered a larger share in the Asia Pacific bioprocess technology market.

Based on end-use, the Asia Pacific Bioprocess technology market is segmented into academic & medical institutions, biopharmaceutical companies, research laboratories, and others. In 2023, the biopharmaceutical companies segment registered the largest share in the Asia Pacific bioprocess technology market.

Based on country, the Asia Pacific Bioprocess technology market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. In 2023, China segment registered a largest share in the Asia Pacific bioprocess technology market.

Corning Inc; Danaher Corp; Eppendorf SE; Lonza Group AG; Merck KGaA; Repligen Corp; Sartorius AG; and Thermo Fisher Scientific Inc are some of the leading companies operating in the Asia Pacific bioprocess technology market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific bioprocess technology market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific bioprocess technology market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the bioprocess technology market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Asia Pacific Bioprocess Technology Market - by Type
    • 1.3.2 Asia Pacific Bioprocess Technology Market - by Modality
    • 1.3.3 Asia Pacific Bioprocess Technology Market - by End User
    • 1.3.4 Asia Pacific Bioprocess Technology Market - by Country

2. Asia Pacific Bioprocess Technology Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Bioprocess Technology Market - Market Landscape

  • 4.1 Overview
  • 4.2 Asia Pacific PEST Analysis
  • 4.3 Expert's Opinion

5. Asia Pacific Bioprocess Technology Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Growing R&D Spendings to Introduce New Drug Compounds
    • 5.1.2 Increasing Prevalence of Chronic Diseases
  • 5.2 Market Restraints
    • 5.2.1 Stringent Regulatory Policies
  • 5.3 Market Opportunities
    • 5.3.1 Introducing Advanced Bioprocess Technologies
  • 5.4 Future Trends
    • 5.4.1 Emergence of Automated Real-Time Flow Cytometry (ART-FCM)
  • 5.5 Impact Analysis

6. Bioprocess Technology Market - Asia Pacific Analysis

  • 6.1 Asia Pacific Bioprocess Technology Market Revenue Forecast and Analysis

7. Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 - by Type

  • 7.1 Overview
  • 7.2 Bioprocess Technology Market Revenue Share, by Type 2022 & 2028 (%)
  • 7.3 Cell Culture Media Bioprocess
    • 7.3.1 Overview
    • 7.3.2 Cell Culture Media Bioprocess: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Chromatography Bioprocess
    • 7.4.1 Overview
    • 7.4.2 Chromatography Bioprocess: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Consumables & Accessories
    • 7.5.1 Overview
    • 7.5.2 Consumables & Accessories: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)

8. Asia Pacific Bioprocess Technology Market Analysis and Forecasts to 2028 - by Modality

  • 8.1 Overview
  • 8.2 Asia Pacific Bioprocess Technology Market, by Modality 2022 & 2028 (%)
  • 8.3 Single Use
    • 8.3.1 Overview
    • 8.3.2 Single Use: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Multiple Use
    • 8.4.1 Overview
    • 8.4.2 Multiple Use: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)

9. Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 - by End User

  • 9.1 Overview
  • 9.2 Asia Pacific Bioprocess Technology Market Revenue Share, by End User 2022 & 2028 (%)
  • 9.3 Academic & Medical Institutions
    • 9.3.1 Overview
    • 9.3.2 Academic & Medical Institutions: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Biopharmaceutical Companies
    • 9.4.1 Overview
    • 9.4.2 Biopharmaceutical Companies: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Research Laboratories
    • 9.5.1 Overview
    • 9.5.2 Research Laboratories: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)

10. Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 - Country Analysis

  • 10.1 Overview
    • 10.1.1 Asia Pacific: Bioprocess Technology Market, by Country, 2022 & 2028 (%)
      • 10.1.1.1 China: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.1.1 Overview
        • 10.1.1.1.2 China: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.1.3 China: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.1.1.1.4 China: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.1.1.1.5 China Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.1.1.2 Japan: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 Japan: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.2.3 Japan: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.1.1.2.4 Japan: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.1.1.2.5 Japan: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.1.1.3 India: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 India: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.3.3 India: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.1.1.3.4 India: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.1.1.3.5 India: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.1.1.4 South Korea: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.4.1 Overview
        • 10.1.1.4.2 South Korea: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.4.3 South Korea: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.1.1.4.4 South Korea: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.1.1.4.5 South Korea: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.1.1.5 Australia: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.5.1 Overview
        • 10.1.1.5.2 Australia: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.5.3 Australia: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.1.1.5.4 Australia: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.1.1.5.5 Australia: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.1.1.6 Rest of Asia Pacific: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.6.1 Overview
        • 10.1.1.6.2 Rest of Asia Pacific: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.6.3 Rest of Asia Pacific: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.1.1.6.4 Rest of Asia Pacific: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.1.1.6.5 Rest of Asia Pacific: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)

11. Asia Pacific Bioprocess Technology Market - Industry Landscape

  • 11.1 Overview
  • 11.2 Organic Growth Strategies
    • 11.2.1 Overview
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview

12. Company Profiles

  • 12.1 Merck KGaA
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Sartorius AG
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Thermo Fisher Scientific Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Corning Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Lonza Group AG
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Eppendorf SE
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Repligen Corp
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Danaher Corp
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Asia Pacific Bioprocess Technology Market, Revenue and Forecast, 2020-2028 (US$ Million)
  • Table 2. China Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. China Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. China Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. Japan Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. Japan Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. Japan Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. India Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. India Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. India Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. South Korea Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. South Korea Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. South Korea Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Australia Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Australia Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Australia Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Rest of Asia Pacific Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Rest of Asia Pacific Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. Rest of Asia Pacific Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 20. Recent Organic Growth Strategies in Bioprocess Technology Market
  • Table 21. Recent Inorganic Growth Strategies in the Asia Pacific bioprocess technology market
  • Table 22. Glossary of Terms

List Of Figures

  • Figure 1. Asia Pacific Bioprocess Technology Market Segmentation
  • Figure 2. Asia Pacific Bioprocess Technology Market, by Country
  • Figure 3. Asia Pacific Bioprocess Technology Market Overview
  • Figure 4. Others Segment Held Largest Share of Type Segment in Asia Pacific Bioprocess Technology Market
  • Figure 5. India Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. Asia Pacific: PEST Analysis
  • Figure 7. Experts' Opinion
  • Figure 8. Asia Pacific Bioprocess Technology Market Impact and Analysis
  • Figure 9. Asia Pacific Bioprocess Technology Market - Revenue Forecast and Analysis - 2020-2028
  • Figure 10. Bioprocess Technology Market Revenue Share, by Type 2022 & 2028 (%)
  • Figure 11. Cell Culture Media Bioprocess: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 12. Chromatographic Bioprocess: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. Consumables & Accessories: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 14. Others: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 15. Asia Pacific Bioprocess Technology Market, by Modality 2022 & 2028 (%)
  • Figure 16. Single Use: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 17. Multiple Use: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 18. Asia Pacific Bioprocess Technology Market Revenue Share, by End User 2022 & 2028 (%)
  • Figure 19. Academic & Medical Institutions: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Biopharmaceutical Companies: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Research Laboratories: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Others: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Asia Pacific: Bioprocess Technology Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 24. China: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Japan: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. India: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. South Korea: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. Australia: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Rest of Asia Pacific: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)